Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia
Background/Aims Adherence to tyrosine kinase inhibitors (TKIs) has become a critical aspect of care in chronic myeloid leukemia (CML). We aimed to examine the association of TKI adherence with overall survival (OS) outcomes in Korean patients diagnosed with CML and treated with TKIs using data from...
Guardado en:
Autores principales: | Yundeok Kim, Tae-Hwa Go, Jaeyeon Jang, Jii Bum Lee, Seung Taek Lim, Kwang Yong Shim, Jong In Lee, Jee Hyun Kong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
The Korean Association of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1650ede77cf4f2bb35f4fb69c3c8a46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
por: Tan BK, et al.
Publicado: (2021) -
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
por: Petrushev B, et al.
Publicado: (2016) -
Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
por: Brittany M. Smith, et al.
Publicado: (2021) -
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
por: Carrà G, et al.
Publicado: (2019) -
The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patient: a literature review
por: Muhammad Darwin Prenggono, et al.
Publicado: (2021)